Type 1 Diabetes Trial, Recruiting (NCT04783441)

Type 1 Diabetes Trial, Recruiting NCT04783441 Sponsor: University of California, Davis Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT04783441 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who have received a kidney transplant within the past year, with the transplanted kidney still working at an acceptable level
People who have Type 2 Diabetes and are currently using insulin
People who have access to a home wi-fi connection

Who may not be able to join:

People who have Type 1 Diabetes
People currently taking a medication called hydroxyurea
People who are unable to wear the Dexcom G6 continuous glucose monitoring device at all times for any reason
People who are unable to check their blood sugar levels using a finger-prick meter at least 4 times per day during certain parts of the study
People with significant vision problems or difficulties with thinking and memory that could affect participation
People who are not able to read or write
People who are currently incarcerated
Women who are pregnant, planning to become pregnant during the study, or currently breastfeeding
People with serious heart or cardiovascular disease that is not stable
People currently undergoing treatment for cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ling Chen, MD, UCDavis Transplant Nephrology

Phone: 916-734-4009

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04783441

Sponsor: University of California, Davis

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 916-734-4009

More information: https://clinicaltrials.gov/study/NCT04783441

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who have received a kidney transplant within the past year, with the transplanted kidney still working at an acceptable level
People who have Type 2 Diabetes and are currently using insulin
People who have access to a home wi-fi connection

Who may not be able to join:

People who have Type 1 Diabetes
People currently taking a medication called hydroxyurea
People who are unable to wear the Dexcom G6 continuous glucose monitoring device at all times for any reason
People who are unable to check their blood sugar levels using a finger-prick meter at least 4 times per day during certain parts of the study
People with significant vision problems or difficulties with thinking and memory that could affect participation
People who are not able to read or write
People who are currently incarcerated
Women who are pregnant, planning to become pregnant during the study, or currently breastfeeding
People with serious heart or cardiovascular disease that is not stable
People currently undergoing treatment for cancer

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Davis

Registry

ClinicalTrials.gov

Start date

29 June 2021

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time in Range (70-180 mg/dl)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov